[ad_1]
“We have nothing to hide: the Minister of Health has asked our service to provide an assessment of the recommendations on how to proceed with the AstraZeneca vaccine, as 16 countries in Europe have decided against us to temporarily suspend vaccination with one or all their series. We made that recommendation and the ministry made such a decision taking it into account “, said G. Andrulionis in the program” Delfi diena “.
According to him, it was decided to make this recommendation precisely because he is awaiting answers to questions posed by states about cases of thromboembolism.
“Are they determined by the vaccine or not? Is it necessary to correct, review the vaccination registration documents, record additional risks? Is it necessary to distinguish some age groups as higher risk and unvaccinated? “All of these things are highly appreciated and the strongest agencies in Europe (Germany, which has many professors specializing in these subjects) have made the same decision, waiting for a formal clarification and any doubts about the safety of the vaccine dispelled,” he said. the director of IWT.
He said there is currently no evidence to confirm or rule out these risks.
“The European Medicines Agency (EMA) has so far not issued any conclusions, only the position that the benefit-risk balance remains favorable,” Andrulionis said.
“What is happening now is a series of committee meetings to evaluate the preclinical and clinical trials, their data and all the possible hypotheses to be answered,” he added.
Gytis Andrulionis
There has been an increase in reports of side effects.
According to G. Andrulionis, there are currently 4 cases in Lithuania where the population experienced serious adverse effects after vaccination with the AstraZeneca vaccine. The data on these cases are usually transmitted by health professionals. Three out of four people who experienced serious side effects are hospitalized.
“The last one is an acute myocardial infarction the day after vaccination,” Andrulionis said.
It says there has been a recent increase in notifications, which are being assessed and, if there are risks, information about them will be passed on to the EVA. At present, not all the most serious cases recorded in Lithuania have been transmitted to the EEA.
“It just came to our attention then. Serious cases are transmitted within a time frame, mild cases within 90 days. <…> It is not just four of those cases, we have received many more of those reports, a total of fifteen hundred about adverse reactions. We evaluate each case and, if we find that there are links, there may be a risk, after a complete evaluation, we pass the EVA ”, he explained.
“In fact, there are many serious and unexpected adverse reactions to this vaccine in the EU. The EVA investigates 30 cases as a registered fact, but there are more. Still today it was agreed that the Member States will present additional cases, which appear to be numerous and that up to the moment they have not been recorded ”, said the head of IWT.
According to G. Andrulionis, on Wednesday some countries confirmed that several cases were registered on Monday and Tuesday, these cases are exceptionally reported, so the figures are constantly changing.
“There are, nobody hides them, that’s why this fuss happened and I stop,” the IWT director told Delfi Day.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to cite DELFI as the source. .
[ad_2]
